- Preview Available
- Scholarly Journal
866 RBN-2397, a novel, potent, and selective PARP7 inhibitor, induces tumor-intrinsic type I interferon responses and adaptive immunity in preclinical models and patient tumors
Kuplast-Barr, Kristy; Johnson, Melissa; Patel, Manish; Yap, Timothy; Falchook, Gerald
; et al.
Journal for Immunotherapy of Cancer; London Vol. 9, Iss. Suppl 2, (Nov 2021): A907-A907.
DOI:10.1136/jitc-2021-SITC2021.866
We're sorry, there is no preview available.
Try and log in through your library or institution to see if they have access.
